Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)

Omega- 3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder With (OMNeADHD) A Double Blind Randomized Controlled Trial of High Dose Omega- 3 Fatty Acids in Children and Adolescents With ADHD With Omega- 3 Deficiency.

This is a 12 week randomized controlled study on the effects of omega-3 fatty acids in youth with attention deficit hyperactivity disorder (ADHD) with omega-3 deficiency.

This is a 12 week randomized controlled study on the effects of omega-3 fatty acids (EPA or DHA) in youth with attention deficit hyperactivity disorder (ADHD) with omega-3 deficiency.

Inclusion Criteria:

1. DSM-5 diagnosis of ADHD
2. Did not have any changes of ADHD treatment (pharmacological/psychological) within 4 weeks of entering the trial.
3. SNAP-IV inattention subscale >=12, or hyperactivity subscale >=12, or inattention+ hyperactivity subscales >=24

Exclusion Criteria:

1. IQ<80
2. Allergic to omega-3
3. Physical disorders: thyroid function, cancer
4. Psychiatric comorbidity: SUD, psychotic disorders, bipolar disorder, major depressive disorder